Glendale Adventist Health Medical Center
Glendale, CA
Accepting patients
TL118
A Phase 2 Study of TL118 for the Treatment of Patients With Solid Tumors Harboring NTRK Gene Fusions
- Tropomyosin Receptor Kinase (TRK) Inhibitor
- Phase 2
Accepting patients